Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of preoperative chemoradiation versus chemoradiation with weekly cisplatin and gemcitabine in FIGO IB2-IIB cervical cancer
ISRCTN88773338Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cisplatin and gemcitabine in Cervical Cancer (CC) (2 arms), sponsored by National Cancer Institute. Primary endpoints: Overall survival and Progression-free survival. Started Sep 2004; status: completed.
02
Drugs
cisplatingemcitabine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ISRCTN88773338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN88773338.